Michael Raynor
Associate Professor, Innovation & Strategy
Dr. Michael E. Raynor focuses on the challenges of innovation, strategy, and managing uncertainty. For more than 30 years, he has contributed to the advancement of management practice through research and consulting across a range of industries.
His books, which include The Innovator's Solution and The Strategy Paradox, are critically-acclaimed bestsellers (New York Times, Globe & Mail) and international award-winners internationally (BusinessWeek, Financial Times). He has published more than one hundred articles and monographs that have shaped management discourse over decades, appearing in many of the world's leading outlets (Harvard Business Review, Strategic Management Journal).
Michael educates future and current business leaders in Ivey's full-time, part-time and executive programs. Over more than 25 years, 15 as a Managing Director with Deloitte, he has broken new ground in applying his insights to address the defining challenges of many of the world's leading organizations in life sciences, medical devices, telecommunications, high technology, financial services, media, and consumer products. He has helped clients with competitive and corporate strategy, product and service innovation, risk management.
Most recently, he has been working to accelerate global decarbonization through transformative new emissions-reduction strategies for hard-to-abate industrial sectors. He aims to continue working with the most ambitious organizations to bring inventive new ideas to bear on the world’s most challenging problems.
From theory to practice: Raynor is also the co-founder of S3 Markets, an Austin, Texas-based venture focused on accelerating decarbonization in hard-to-abate sectors by transforming carbon markets to empower corporate climate action. And he is a founding investor and senior advisor to Canary Medical, a Vancouver-based med-tech company that combines smart implantable medical devices with artificial intelligence to improve patient outcomes and revolutionize healthcare.
Michael has a doctorate from the Harvard Business School, where he was recognized with the Dively Award for research excellence; an MBA with distinction from Ivey Business School, where he received the Nelson M. Davis Memorial Scholarship; and an undergraduate degree in Philosophy magna cum laude from Harvard University, where he was a Detur Prize winner.